KL-6, a mucin-associated glycoprotein, may be a trigger for transforming growth factor beta(TGF-β) signalling and fibrosis (28, 29), giving it the potential to be a biomarker not only of the presence of ILD but also of disease activity. This evidence concerns the gene MUC1 and interstitial lung disease.